跳至主要内容
临床试验/NL-OMON32545
NL-OMON32545招募中不适用

The added value of MRI for detection of prostate cancer: validation with MR guided biopsies, fusion of MRI and transrectal ultrasound guided biopsies and TRUS guided biopsies. - Detection of prostate cancer: MRGB, TRUSGB and MRUSFGB

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • PSA>=4.0 ng/ml
  • One or more previous negative TRUS guided prostate biopsies

排除标准

  • Patients with known contradictions to MRI
  • Patients with known contra-indications to Gadolinium based contrast agents.
  • Patients with previous radiotherapy, hormonal therapy or local treatment of the prostate.
  • Patients with histological prove of prostate cancer

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验